Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | HSPB1 | P04792 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737640 | 0.86 | TDP1 (0.53) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL29362511 | 0.81 | TDP1 (0.60) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL310839 | 0.81 | TDP1 (0.60) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL7158569 | 0.81 | PTGES (0.51) | TDP1ATMALDH1A1MAPTMAPK1 | |
| SCHEMBL1414035 | 0.80 | ATM (0.58) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL30800770 | 0.80 | TDP1 (0.58) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL525939 | 0.80 | TDP1 (0.58) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL2891144 | 0.80 | TDP1 (0.58) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL10757303 | 0.80 | ATM (0.58) | TDP1ATMHSPB1ALDH1A1MAPT | |
| SCHEMBL5860358 | 0.80 | MAOB (0.48) | TDP1ATMHSPB1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113024454-B | Synthesis method of brigatinib intermediate | 浙江工业大学 | 2022-09-09 | — | — | CN | claimed |
| CN-112239422-B | Bugatinib intermediate, salt thereof, preparation method thereof and preparation method of brigatinib | 河北化工医药职业技术学院 | 2022-07-22 | — | — | CN | claimed |
| CN-113024454-A | Synthesis method of brigatinib intermediate | 浙江工业大学 | 2021-06-25 | — | — | CN | claimed |
| CN-112239422-A | Bugatinib intermediate, salt thereof, preparation method thereof and preparation method of brigatinib | 河北化工医药职业技术学院 | 2021-01-19 | — | — | CN | claimed |
| CN-106883216-B | Preparation method of oxitinib | 张家港威胜生物医药有限公司 | 2020-03-13 | — | — | CN | claimed |
| CN-115947728-A | Dihydro pteridinone derivative containing sulfonyl and application thereof | 沈阳药科大学 | 2023-04-11 | — | — | CN | disclosed |
| CN-115916759-A | Substituted quinazoline compound, preparation method, pharmaceutical composition and application thereof | 南京红云生物科技有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115716850-A | Crystal form, preparation method and application of aryl phosphorus oxide compound | 成都地奥九泓制药厂 | 2023-02-28 | — | — | CN | disclosed |
| CN-115677773-A | Aryl phosphorus oxygen compound and application thereof | 成都地奥九泓制药厂 | 2023-02-03 | — | — | CN | disclosed |
| CN-115697996-A | Alkenyl pyrimidine compound, preparation method and application thereof | 南京红云生物科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-113382991-B | Aminopyrimidines useful for inhibiting protein tyrosine kinase activity | 深圳市塔吉瑞生物医药有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-115348963-A | Pyridopyrimidine compound and application thereof | 暨南大学 | 2022-11-15 | — | — | CN | disclosed |
| CN-111393377-A | Deuterated pyrimidine derivative with anticancer effect | 四川大学华西医院 | 2020-07-10 | — | — | CN | disclosed |
| CN-111138492-A | Preparation method of ALK inhibitor brigatinib | 沈阳药科大学 | 2020-05-12 | — | — | CN | disclosed |
| CN-106883216-B | Preparation method of oxitinib | 张家港威胜生物医药有限公司 | 2020-03-13 | — | — | CN | disclosed |
| CN-106883216-B | Preparation method of oxitinib | 张家港威胜生物医药有限公司 | 2020-03-13 | — | — | CN | disclosed |
| CN-110818690-A | Aminopyrimidines useful for inhibiting protein tyrosine kinase activity | 深圳市塔吉瑞生物医药有限公司 | 2020-02-21 | — | — | CN | disclosed |
| CN-108602802-B | Aminopyrimidines useful for inhibiting protein tyrosine kinase activity | 深圳市塔吉瑞生物医药有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110590548-A | AKR1C3 inhibitor or pharmaceutically acceptable salt thereof, preparation method and application thereof | 中国药科大学 | 2019-12-20 | — | — | CN | disclosed |
| CN-104968654-A | Substituted 2-aminopyridine protein kinase inhibitor | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD | 2015-10-07 | — | — | CN | disclosed |